FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 4151380 · Received October 8, 2014

Report

Report Number
1030489-2014-03908
Event Type
Injury
Date Received
October 8, 2014
Report Date
October 24, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON: (B)(6) 2010: PATIENT PRESENTED WITH PREOPERATIVE DIAGNOSIS OF DEGENERATIVE DISC DISEASE OF L3-4, L4-5 AND UNDERWENT DIRECT LATERAL INTERBODY FUSION(L3-4,L4-5) WITH PERCUTANEOUS PEDICLE SCREW FIXATION. THERE WERE NO COMPLICATIONS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT AN ANTERIOR LUMBAR FUSION AT L3-4, L4-5 USING RHBMP-2/ACS PLACED INSIDE OF A PEEK CAGE. FOLLOWING THE SURGERY, THE PATIENT DEVELOPED FURTHER BACK PAIN. CONSEQUENTLY, THE PATIENT UNDERWENT ADDITIONAL IMAGING. CT SCANS PERFORMED IN 2011 AND 2013 DEMONSTRATED THAT THE PATIENT HAD DEVELOPED ECTOPIC BONE GROWTH. THE PATIENT HAS NEVER RECOVERED FROM HIS SURGERY, AND HE HAS DAILY, DISABLING PAIN THAT PREVENTS HIM FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
632379 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA M110805AAL

Patients

Seq Age Sex Outcome Treatment
1 Other